drugset / Trial / NCT03967730

Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication

NCT03967730

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to evaluate the safety and efficacy of sonodynamic therapy (SDT) in reducing the inflammation of perivascular adipose tissue and increasing peak walking time (PWT) among peripheral artery disease (PAD) patients with symptom of intermittent claudication.

Timeline

Start
2019-06-20
Primary completion
2020-05-30
Completion
2020-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinoporphyrin sodium Other / unclassified 0.2 mg/kg Intravenous